41 – 50 of 81
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Identification of new susceptibility loci for type 2 diabetes and shared etiological pathways with coronary heart disease
(
- Contribution to journal › Article
-
Mark
Distribution of indications and procedures within the framework of centers participating in the WAA apheresis registry
(
- Contribution to journal › Scientific review
-
Mark
Smoking impacts endogenous estradiol and testosterone levels in young healthy women
2017) American Association for Cancer Research (AACR) 108th Annual Meeting 2017 In Cancer Research 77(13 Suppl).(
- Contribution to journal › Published meeting abstract
-
Mark
Body constitution in young healthy women from breast cancer higher risk families in relation to smoking
2017) American Association for Cancer Research (AACR) 108th Annual Meeting 2017 In Cancer Research 77(13).(
- Contribution to journal › Published meeting abstract
-
Mark
A low-frequency inactivating AKT2 variant enriched in the finnish population is associated with fasting insulin levels and type 2 diabetes risk
(
- Contribution to journal › Article
- 2016
-
Mark
Patterns of somatic diagnoses in older people with intellectual disabilities : A Swedish 11-year register-based study of inpatient data
(
- Contribution to journal › Published meeting abstract
-
Mark
Drug use and healthcare consumption among persons with intellectual disabilities and dementia: A registry study
(
- Contribution to journal › Published meeting abstract
-
Mark
Patterns of somatic healthcare utilisation in people with intellectual disabilities: A Swedish 11-year register-based study
(
- Contribution to journal › Published meeting abstract
-
Mark
Development after pediatric brain tumor-a longitudinal study
(
- Contribution to journal › Article
-
Mark
Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: Raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART
(
- Contribution to journal › Article